PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 209 filers reported holding PDL BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $106,000 | -90.7% | 49,093 | -86.4% | 0.00% | -100.0% |
| Q2 2019 | $1,136,000 | -47.9% | 361,681 | -38.3% | 0.00% | -42.9% |
| Q1 2019 | $2,180,000 | +25.7% | 586,148 | -2.0% | 0.01% | 0.0% |
| Q4 2018 | $1,734,000 | +70.5% | 597,864 | +54.6% | 0.01% | +133.3% |
| Q3 2018 | $1,017,000 | +148.7% | 386,828 | +121.5% | 0.00% | +200.0% |
| Q2 2018 | $409,000 | -71.5% | 174,603 | -64.2% | 0.00% | -80.0% |
| Q1 2018 | $1,435,000 | -40.2% | 487,989 | -44.3% | 0.01% | -37.5% |
| Q4 2017 | $2,399,000 | -39.5% | 875,481 | -25.2% | 0.01% | -42.9% |
| Q3 2017 | $3,967,000 | +105.7% | 1,170,199 | +49.8% | 0.01% | +100.0% |
| Q2 2017 | $1,929,000 | +30.3% | 781,016 | +19.8% | 0.01% | +40.0% |
| Q1 2017 | $1,480,000 | -20.1% | 652,160 | -25.4% | 0.01% | -28.6% |
| Q4 2016 | $1,852,000 | -41.4% | 873,708 | -7.5% | 0.01% | -36.4% |
| Q3 2016 | $3,163,000 | -10.4% | 944,202 | -16.0% | 0.01% | -26.7% |
| Q2 2016 | $3,529,000 | -24.4% | 1,123,893 | -19.8% | 0.02% | -31.8% |
| Q1 2016 | $4,669,000 | -31.6% | 1,402,072 | -27.2% | 0.02% | -33.3% |
| Q4 2015 | $6,822,000 | +77.4% | 1,927,062 | +152.0% | 0.03% | +65.0% |
| Q3 2015 | $3,846,000 | -65.7% | 764,569 | -56.1% | 0.02% | -61.5% |
| Q2 2015 | $11,211,000 | -17.1% | 1,743,570 | -9.3% | 0.05% | -22.4% |
| Q1 2015 | $13,531,000 | +2537.6% | 1,923,393 | +2791.4% | 0.07% | +2133.3% |
| Q4 2014 | $513,000 | -70.3% | 66,521 | -71.2% | 0.00% | -62.5% |
| Q3 2014 | $1,726,000 | -24.6% | 231,000 | -2.3% | 0.01% | -20.0% |
| Q2 2014 | $2,288,000 | -82.5% | 236,319 | -85.0% | 0.01% | -85.7% |
| Q1 2014 | $13,105,000 | +274.6% | 1,576,957 | +280.5% | 0.07% | +268.4% |
| Q4 2013 | $3,498,000 | -67.3% | 414,485 | -69.1% | 0.02% | -72.1% |
| Q3 2013 | $10,684,000 | +16.3% | 1,340,485 | +12.7% | 0.07% | +6.2% |
| Q2 2013 | $9,186,000 | – | 1,189,803 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |